|
Market Closed -
Euronext Paris
01:55:00 29/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.8090 EUR | +0.25% |
|
-0.12% | +16.57% |
| 23/07 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 29/06 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.25% | -0.12% | +5.06% | -31.44% | +16.57% | -5.82% | -81.61% | -87.72% | - | 22.21M | |
| -1.59% | -3.35% | +27.95% | +56.15% | +73.65% | +64.49% | +98.69% | +21.13% | - | 69.54B | |
| -1.34% | -0.75% | +15.96% | +24.51% | +24.89% | +48.56% | +90.63% | +210.83% | +6,531.11% | 64.97B | |
| -8.37% | -12.43% | +10.41% | +9.24% | +7.22% | +0.14% | -15.42% | -71.53% | - | 25.64B | |
| -2.35% | -5.75% | +13.84% | +9.38% | -31.89% | -12.17% | +448.29% | +341.00% | +796.67% | 25.89B | |
| +0.30% | -0.69% | +31.29% | +56.42% | +61.10% | +63.18% | +11.93% | -56.34% | - | 26.51B | |
| -0.96% | +10.36% | +38.57% | +98.82% | +264.65% | +278.86% | +438.78% | +1,783.06% | +1,015.48% | 20.22B | |
| -0.51% | +0.23% | +13.00% | +26.86% | +6.36% | +33.71% | -18.02% | -27.89% | +97.07% | 19.98B | |
| -1.91% | -4.37% | +1.18% | +15.10% | +31.18% | +13.33% | +531.29% | - | - | 15.69B | |
| -1.47% | +0.68% | -3.65% | +5.83% | +24.23% | +43.67% | +145.49% | +180.24% | +396.81% | 13.49B | |
| -1.83% | +3.29% | -0.94% | +3.45% | -8.34% | +22.09% | +195.17% | +543.08% | +5,572.26% | 12.33B | |
| -4.15% | -2.53% | -1.01% | +7.41% | +27.90% | +280.08% | +206.98% | +28.52% | +1,121.73% | 11.99B | |
| -5.78% | +5.65% | -0.68% | -13.63% | -15.62% | -37.35% | +180.44% | +160.88% | - | 11.2B | |
| -4.19% | +4.33% | +9.40% | -21.14% | -21.50% | -43.78% | +675.71% | +66.02% | +89.48% | 10.95B | |
| -7.46% | -6.18% | -9.26% | -6.15% | +13.46% | +93.01% | +100.92% | +116.62% | +489.45% | 10.02B | |
| -2.16% | -4.45% | +9.59% | +17.19% | +29.68% | +94.46% | +16.52% | +124.61% | - | 8.9B | |
| -0.01% | +0.18% | +1.17% | +135.60% | +82.26% | +176.80% | +398.18% | +262.25% | - | 9B | |
| -4.17% | +3.34% | +15.49% | +4.27% | +306.57% | +245.49% | +387.88% | -28.89% | - | 8.53B | |
| +1.58% | +6.21% | -1.12% | +6.14% | +16.39% | -4.77% | +124.06% | -15.69% | - | 8.51B | |
| -3.48% | -15.15% | -9.60% | +25.31% | +175.82% | +440.43% | +580.29% | -50.89% | -38.69% | 7.97B | |
| Average | -2.22% | -1.14% | +8.33% | +21.47% | +54.23% | +89.72% | +225.81% | +184.17% | +1,607.14% | 19.07B | |
| Weighted average by Cap. | -2.17% | -1.16% | +14.59% | +30.60% | +50.16% | +72.83% | +186.50% | +196.92% | +2,833.48% |
- Stock Market
- Stocks
- ALVAL Stock
- Sector Valbiotis
Select your edition
All financial news and data tailored to specific country editions
